Form 8-K - Current report:
SEC Accession No. 0001493152-20-005395
Filing Date
2020-03-31
Accepted
2020-03-31 06:31:00
Documents
3
Period of Report
2020-03-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32531
2 ex99-1.htm EX-99.1 1287
3 ex99-1_001.jpg GRAPHIC 88740
  Complete submission text file 0001493152-20-005395.txt   157501
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 20759555
SIC: 7389 Services-Business Services, NEC